Double Medical Technology Inc. (SHE: 002901)
China
· Delayed Price · Currency is CNY 35.12
-0.43 (-1.21%)
Jan 27, 2025, 3:04 PM CST
Double Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 201.13 | 58.97 | 92.56 | 673.31 | 605.68 | 465.49 | Upgrade
|
| Depreciation & Amortization | 108.89 | 108.89 | 95.51 | 70.85 | 50.33 | 39.79 | Upgrade
|
| Other Amortization | 85.5 | 85.5 | 42 | 11.2 | 1.25 | 1.87 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.3 | -0.3 | 1.73 | 0 | 0.12 | -0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.88 | 0.88 | 1.91 | 0.94 | 0.06 | 0.6 | Upgrade
|
| Loss (Gain) From Sale of Investments | -15.35 | -15.35 | -17.98 | -21.41 | -7.33 | -6.74 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.92 | -0.92 | -2.07 | 16.24 | 8.3 | 12.31 | Upgrade
|
| Other Operating Activities | 113.51 | 57.26 | 4.52 | 18.43 | 1.65 | 5.5 | Upgrade
|
| Change in Accounts Receivable | 86.8 | 86.8 | 121.91 | -179.38 | -69.35 | -175.26 | Upgrade
|
| Change in Inventory | -422.18 | -422.18 | -418.26 | -140.44 | -91.31 | -196.55 | Upgrade
|
| Change in Accounts Payable | 118.13 | 118.13 | 103.13 | 189.28 | 44.54 | 289.11 | Upgrade
|
| Change in Other Net Operating Assets | - | - | 105.55 | 38.08 | 13.41 | - | Upgrade
|
| Operating Cash Flow | 272.28 | 73.86 | 128.44 | 673.26 | 555.77 | 433.88 | Upgrade
|
| Operating Cash Flow Growth | 168.55% | -42.50% | -80.92% | 21.14% | 28.09% | 29.56% | Upgrade
|
| Capital Expenditures | -298.71 | -305.72 | -285.07 | -235.11 | -137.13 | -319.29 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.03 | 1.59 | 0.44 | 0.01 | 0.1 | 0.18 | Upgrade
|
| Cash Acquisitions | - | - | 1.66 | -88.02 | - | - | Upgrade
|
| Investment in Securities | 93.23 | -213.77 | 40.75 | -96.03 | -143.72 | 46.61 | Upgrade
|
| Other Investing Activities | 252.73 | 11.93 | 16.74 | 22.59 | 4.63 | 3.52 | Upgrade
|
| Investing Cash Flow | 47.23 | -508.01 | -225.61 | -396.76 | -276.12 | -268.98 | Upgrade
|
| Long-Term Debt Issued | - | 532.61 | 50.77 | 1.11 | - | - | Upgrade
|
| Total Debt Issued | 190.43 | 532.61 | 50.77 | 1.11 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -12.33 | -11.36 | -8.33 | - | - | Upgrade
|
| Total Debt Repaid | -303.21 | -12.33 | -11.36 | -8.33 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -112.78 | 520.28 | 39.41 | -7.22 | - | - | Upgrade
|
| Issuance of Common Stock | - | - | 488.32 | 79.34 | - | 7.93 | Upgrade
|
| Repurchase of Common Stock | - | - | -75.68 | -2.92 | -2.35 | - | Upgrade
|
| Common Dividends Paid | -118.94 | -9.43 | -209.38 | -324.11 | -241.34 | -200.97 | Upgrade
|
| Other Financing Activities | -72.28 | -14.65 | 2.5 | -4.42 | -11.95 | -5.91 | Upgrade
|
| Financing Cash Flow | -303.99 | 496.2 | 245.16 | -259.33 | -255.64 | -198.94 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.33 | 1.06 | 4.31 | -3.55 | -13.48 | 1.93 | Upgrade
|
| Net Cash Flow | 15.18 | 63.11 | 152.3 | 13.61 | 10.53 | -32.11 | Upgrade
|
| Free Cash Flow | -26.44 | -231.85 | -156.63 | 438.15 | 418.64 | 114.59 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 4.66% | 265.34% | -50.50% | Upgrade
|
| Free Cash Flow Margin | -1.36% | -15.12% | -10.92% | 21.97% | 26.38% | 9.11% | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.55 | -0.37 | 1.09 | 1.04 | 0.29 | Upgrade
|
| Cash Income Tax Paid | 141.25 | 106.5 | 210.18 | 310.97 | 240.93 | 185.02 | Upgrade
|
| Levered Free Cash Flow | -69.08 | -105.81 | -240.44 | 303.33 | 173.7 | 53.96 | Upgrade
|
| Unlevered Free Cash Flow | -63.46 | -101.33 | -238.5 | 303.68 | 173.7 | 53.96 | Upgrade
|
| Change in Net Working Capital | 67.84 | 2.05 | 207.01 | 24.49 | 136.43 | -25.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.